Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

Clinical trial NCT03445637 · COMPLETED

Trial details

NCT number: NCT03445637
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasm

Start date: 2018-02-08
Primary completion: 2025-07-13
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.